Dynamic relationship between infantile hepatitis syndrome and cytomegalovirus infection.
Wang G, Feng D.
Exp Ther Med. 2017 Jun;13(6):3443-3447. doi: 10.3892/etm.2017.4375. Epub 2017 Apr 24.
Probiotics to prevent infantile colic.
Ong TG, Gordon M, Banks SS, Thomas MR, Akobeng AK.
Cochrane Database Syst Rev. 2019 Mar 13;3(3):CD012473. doi: 10.1002/14651858.CD012473.pub2.
[Progress in infectious etiology of infantile hepatitis syndrome].
Zheng JJ, Xu HM.
Zhonghua Gan Zang Bing Za Zhi. 2012 Jul;20(7):558-60.
Non-invasive urinary metabolomic profiles discriminate biliary atresia from infantile hepatitis syndrome.
Li WW, Yang Y, Dai QG, Lin LL, Xie T, He LL, Tao JL, Shan JJ, Wang SC.
Metabolomics. 2018 Jun 21;14(7):90. doi: 10.1007/s11306-018-1387-z.
Utility of Shear Wave Elastography for Differentiating Biliary Atresia From Infantile Hepatitis Syndrome.
Wang X, Qian L, Jia L, Bellah R, Wang N, Xin Y, Liu Q.
J Ultrasound Med. 2016 Jul;35(7):1475-9. doi: 10.7863/ultra.15.08031. Epub 2016 May 26.
Ultrasonography for biliary atresia and infantile hepatitis syndrome.
Wiwanitkit V.
Pediatr Surg Int. 2011 May;27(5):551. doi: 10.1007/s00383-011-2888-2. Epub 2011 Mar 25.
[Treatment of infantile hepatitis syndrome with injection of yin zhi huang].
Dong YS, Huang ZH, Wu LF.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 1992 Jan;12(1):26-7, 5-6.
The therapeutic efficacy of the choleretic mixture against the infantile hepatitis syndrome.
Shi YM, Shen YJ, Fu MD, Lu Y.
J Tradit Chin Med. 1989 Jun;9(2):103-5.
Alterations of biliary biochemical constituents and cytokines in infantile hepatitis syndrome.
Ding Y, Zhao L, Mei H, Huang ZH, Zhang SL.
World J Gastroenterol. 2006 Nov 21;12(43):7038-41. doi: 10.3748/wjg.v12.i43.7038.
Polymeric immunoglobulin receptor promotes Th2 immune response in the liver by increasing cholangiocytes derived IL-33: a diagnostic and therapeutic biomarker of biliary atresia.
Li Y, Li TY, Qiao Q, Zhang MT, Tong MX, Xu LF, Zhang ZB.
EBioMedicine. 2024 Oct;108:105344. doi: 10.1016/j.ebiom.2024.105344. Epub 2024 Sep 16.
